|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ISATUXIMAB |
L01FC02 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
RO
|
POM
|
20-11-2023 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
FOSTAMATINIB |
B02BX09 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005012 |
09-01-2020 |
VALID
|
|
ULIPRISTAL |
G03XB02 |
RO
|
I
|
12-11-2018 |
EMEA/H/C/005017 |
09-02-2018 |
VALID
|
|
FEDRATINIB |
L01XE57 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
LUMASIRAN |
A16AX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
LEFAMULIN |
J01XX12 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005048 |
27-07-2020 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
RO
|
I
|
15-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
PONESIMOD |
L04AE04 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
PRETOMANID |
J04AK08 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005167 |
31-07-2020 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
FINERENONE |
C03DA05 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
TIRATRICOL |
H03AA04 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005220 |
12-02-2025 |
VALID
|
|
REMIMAZOLAM |
N05CD14 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
TUCATINIB |
L01EH03 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
RELUGOLIX, ESTRADIOL AND NORETHISTERONE |
H01CC54 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005267 |
16-07-2021 |
VALID
|
|
IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR |
R07AX32 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005269 |
21-08-2020 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
RELUGOLIX |
L02BX04 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
ABROCITINIB |
D11AH08 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
VOSORITIDE |
M05BX07 |
RO
|
I
|
06-12-2021 |
EMEA/H/C/005475 |
26-08-2021 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|